Brett R Hagen Allovir, Inc. (ALVR) insider trading activity

Brett R Hagen is Chief Accounting Officer of Allovir, Inc.. Currently has a direct ownership of 68,506 shares of ALVR, which is worth approximately $31,512. The most recent transaction as insider was on Aug 17, 2023, when has been sold 1,653 shares (Common Stock) at a price of $2.5 per share, resulting in proceeds of $4,132. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 68.5K

4.83% 3M change

29.74% 12M change

Total Value Held $31,512

Brett R Hagen Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 17 2023	SELL Open market or private sale	$4,132 $2.5 p/Share	1,653 Reduced 1.28%	127,175 Common Stock
Jul 20 2023	SELL Open market or private sale	$1,145 $3.35 p/Share	342 Reduced 0.26%	128,828 Common Stock
Jul 19 2023	SELL Open market or private sale	$1,217 $3.56 p/Share	342 Reduced 0.26%	129,170 Common Stock
Jun 09 2023	SELL Open market or private sale	$28,453 $5.64 p/Share	5,045 Reduced 3.75%	129,512 Common Stock
Apr 20 2023	SELL Open market or private sale	$1,266 $3.63 p/Share	349 Reduced 0.26%	134,557 Common Stock
Apr 19 2023	SELL Open market or private sale	$1,291 $3.71 p/Share	348 Reduced 0.26%	134,906 Common Stock
Feb 02 2023	BUY Grant, award, or other acquisition	-	61,250 Added 31.17%	135,254 Common Stock
Jan 20 2023	SELL Open market or private sale	$1,737 $5.14 p/Share	338 Reduced 0.45%	74,004 Common Stock
Jan 19 2023	SELL Open market or private sale	$7,909 $5.08 p/Share	1,557 Reduced 2.05%	74,342 Common Stock
Nov 11 2022	SELL Open market or private sale	$147,329 $8.18 p/Share	18,011 Reduced 19.18%	75,899 Common Stock
Nov 10 2022	SELL Open market or private sale	$47,912 $8.0 p/Share	5,989 Reduced 6.0%	93,910 Common Stock
Oct 24 2022	SELL Open market or private sale	$16,260 $8.13 p/Share	2,000 Reduced 1.96%	99,899 Common Stock
Oct 21 2022	SELL Open market or private sale	$95,772 $8.45 p/Share	11,334 Reduced 10.01%	101,899 Common Stock
Oct 19 2022	SELL Open market or private sale	$3,229 $9.36 p/Share	345 Reduced 0.3%	113,233 Common Stock
Aug 16 2022	BUY Grant, award, or other acquisition	-	20,000 Added 14.97%	113,578 Common Stock
Jul 01 2022	BUY Grant, award, or other acquisition	-	10,500 Added 10.09%	93,578 Common Stock
Apr 20 2022	SELL Open market or private sale	$1,844 $6.68 p/Share	276 Reduced 0.34%	80,368 Common Stock
Jan 20 2022	SELL Open market or private sale	$13,676 $8.75 p/Share	1,563 Reduced 2.41%	63,202 Common Stock
Jan 18 2022	BUY Grant, award, or other acquisition	-	17,442 Added 17.78%	80,644 Common Stock
Feb 22 2021	SELL Open market or private sale	$34,512 $43.14 p/Share	800 Reduced 1.22%	64,765 Common Stock
Feb 18 2021	SELL Open market or private sale	$29,544 $39.87 p/Share	741 Reduced 1.12%	65,565 Common Stock
Feb 17 2021	SELL Open market or private sale	$93,542 $40.32 p/Share	2,320 Reduced 3.38%	66,306 Common Stock
Feb 16 2021	SELL Open market or private sale	$128,832 $42.24 p/Share	3,050 Reduced 4.26%	68,626 Common Stock
Jan 19 2021	BUY Grant, award, or other acquisition	-	17,500 Added 19.62%	71,676 Common Stock

BRH

Brett R Hagen

Chief Accounting Officer

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALVR shares.

Notify only if

Value

Insider Trading

Get notified when an Allovir, Inc. insider buys or sells ALVR shares.

Notify only if

Operation

Value

Type

News

Receive news related to Allovir, Inc.

Track Activities on ALVR

Account